CL
CSS LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 895 |
|
|
2025
Q1 | – | Sell |
-550
| Closed | -$221K | – | 845 |
|
|
2024
Q4 | $221K | Sell |
550
-450
| -45% | -$181K | 0.01% | 517 |
|
|
2024
Q3 | $465K | Buy |
1,000
+300
| +43% | +$140K | 0.02% | 394 |
|
|
2024
Q2 | $328K | Hold |
700
| – | – | 0.02% | 386 |
|
|
2024
Q1 | $293K | Sell |
700
-18,000
| -96% | -$7.52M | 0.02% | 406 |
|
|
2023
Q4 | $7.61M | Sell |
18,700
-300
| -2% | -$122K | 0.44% | 34 |
|
|
2023
Q3 | $6.61M | Sell |
19,000
-300
| -2% | -$104K | 0.43% | 38 |
|
|
2023
Q2 | $6.79M | Buy |
19,300
+1,300
| +7% | +$457K | 0.42% | 38 |
|
|
2023
Q1 | $5.67M | Buy |
18,000
+13,336
| +286% | +$4.2M | 0.37% | 52 |
|
|
2022
Q4 | $1.35M | Buy |
4,664
+1,017
| +28% | +$294K | 0.08% | 173 |
|
|
2022
Q3 | $1.06M | Sell |
3,647
-136
| -4% | -$39.4K | 0.05% | 258 |
|
|
2022
Q2 | $1.07M | Buy |
3,783
+1,134
| +43% | +$320K | 0.04% | 325 |
|
|
2022
Q1 | $691K | Buy |
2,649
+1,149
| +77% | +$300K | 0.03% | 425 |
|
|
2021
Q4 | $329K | Sell |
1,500
-47,560
| -97% | -$10.4M | 0.01% | 640 |
|
|
2021
Q3 | $8.9M | Buy |
49,060
+16,744
| +52% | +$3.04M | 0.38% | 41 |
|
|
2021
Q2 | $6.52M | Buy |
+32,316
| New | +$6.52M | 0.27% | 54 |
|
|
2020
Q2 | – | Sell |
-600
| Closed | -$143K | – | 527 |
|
|
2020
Q1 | $143K | Buy |
+600
| New | +$143K | 0.01% | 300 |
|